Answers are grounded in this paper and cite their sources.
Critical review reveals insufficient biocompatibility evidence for green-synthesized gold and silver nanoparticles in biological models, highlighting the need for rigorous safety testing.
In scientific literature biosynthesis of gold and silver nanoparticles and synthesis of these nanoparticles using small organic molecules such as citrate have been called ´green´. In abstracts of scientific publications gold or silver nanoparticles obtained by ´green´ synthesis have been rather frequently characterized as biocompatible. Biocompatible means: having no negative impact on exposed organisms. Two kinds of reasons have been used as underpinning for this characterization. The first is the biocompatibility of the substances used in ´green´ synthesis and coating nanoparticles. This reason lacks a solid empirical basis. The second reason given for biocompatibility is limited testing of the nanoparticles obtained by ´green´ synthesis, mainly in vitro testing. Such limited testing is inconclusive. Use-specific comprehensive in vitro and in vivo testing, including clinical studies, and control of hazardous substances such as lipopolysaccharide and flagellins is needed to provide a solid basis for the characterization biocompatible for humans.
No takes yet. Share an insight, caveat, or question.
L. Reijnders (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: